Hormone receptor-positive breast cancerNeoadjuvant chemotherapyAdjuvant chemotherapySurvival outcomesSEER databaseGuideline recommendations for the application of neoadjuvant chemotherapy (NACT) in T2N1M0 stage hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer are ambiguous. The debate ...